Paul Jellinger, MD, MACE, on Testing for ASCVD

Paul Jellinger, MD, MACE, from the University of Miami School of Medicine, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of ASCVD.

PART THREE OF THE CASE REPORT

MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)

ASCVD RISK CATEGORIES AND LDL-C TREATMENT GOALS

MESA: CHD EVENT RATES WITH INCREASING CAC SCORE AND BASED ON RISK FACTOR BURDEN

Paul S. Jellinger, MD, MACE, is a professor of clinical medicine at the University of Miami Miller School of Medicine. He is also the Past President of the American Association of Clinical Endocrinologists (AACE) and Past President of the American College of Endocrinology.